All Stories

  1. The Cost of Postoperative Complications and Economic Validation of the Comprehensive Complication Index
  2. The Economic Influence of Breastfeeding on the Health Cost of Newborns
  3. Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?
  4. Social economic costs of COPD in Extremadura (Spain): an observational study
  5. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
  6. Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis
  7. The impact of obesity on health-related quality of life in Spain
  8. Estado de salud, calidad de vida y utilización de recursos sanitarios de los pacientes con diabetes mellitus en España
  9. The Impact of Severe Obesity on Healthcare Resource Utilisation in Spain
  10. Women with urinary incontinence in Spain: Health-related quality of life and the use of healthcare resources
  11. Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position
  12. Quality of life and use of health care resources among patients with chronic depression
  13. Coste-efectividad de una unidad monográfica de asma
  14. Long-term fiscal implications of funding assisted reproduction: a generational accounting model for Spain
  15. Impact Of Heart Failure On Hospital Admissions And Mortality In Spain In The Period 2009-2013
  16. Burden of Disease of Ovarian Cancer in Spain. Ovarcost Study
  17. Analysis of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2014 In Spain
  18. Cost Saving Associated With Glucose Meter Accuraccy In Spain
  19. Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain
  20. Cuestiones controvertidas en evaluación económica (III). Intervenciones sanitarias en tres situaciones especiales: enfermedades raras, tratamientos al final de la vida y externalidades en las evaluaciones
  21. Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD)
  22. Labour productivity losses caused by premature death associated with hepatitis C in Spain
  23. Caregivers’ burden in patients with COPD
  24. Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
  25. Economic valuation of informal care in cerebrovascular accident survivors in Spain
  26. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
  27. Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012
  28. Tratamiento biológico de la artritis reumatoide en España. Análisis de impacto presupuestario de la utilización de certolizumab pegol
  29. Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010
  30. Health- related quality of life in diabetic people with different vascular risk
  31. Análisis coste-efectividad de la fototerapia domiciliaria con ultravioleta B de banda estrecha frente a fármacos biológicos en el tratamiento de la psoriasis moderada-grave
  32. Analysis of the Cost Effectiveness of Home-Based Phototherapy With Narrow-Band UV-B Radiation Compared With Biological Drugs For the Treatment of Moderate to Severe Psoriasis
  33. Teledermatología diferida: análisis de validez en una serie de 2.000 observaciones
  34. Store-and-Forward Teledermatology: Assessment of Validity in a Series of 2000 Observations
  35. Cost‐effectiveness of ambulatory blood pressure monitoring in the follow‐up of hypertension